Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
2.
Drug Dev Ind Pharm ; 32(6): 651-60, 2006 Jul.
Article in English | MEDLINE | ID: mdl-16885120

ABSTRACT

A convenient and reliable method to prepare procaterol HCl oral dosage form at an extremely low dosage (25 microg/cap) is presented in this paper. Procaterol HCl was mixed with the film-forming agent hydroxypropyl methylcellulose in an aqueous solution, which was then spray-coated on sugar spheres (Nu-pareil PG 20/25) to produce procaterol HCl pellets. The IR spectra of coated and noncoated pellets indicated that procaterol HCl was coated on the sugar spheres successfully with a weight increment less than 1%. Most of the coated pellets were able to pass through an 18-mesh screen with no agglomeration. The average weights of coated pellets filled inside of capsules were monitored during the filling process. A simple liquid chromatographic method was developed and validated for the assay and uniformity test of procaterol HCl in different dosage forms. The results of assay and content uniformity test for both in-house product and a commercial product, i.e., Meptin-mini tablet, were satisfied. The data of f(2) function and ANOVA analysis for the dissolution profiles of both procaterol HCl products suggested that they are pharmaceutical equivalent. In an in vivo study (n = 24), a single dose of 75 microg procaterol HCl was administrated to each volunteer and the plasma concentration of procaterol was determined by a LC/MS/MS method, developed by the same authors. There were no significant differences (p > 0.05) in the data of AUC(0-->16 h), AUC(0-->infinity), C(max), and MRT for both preparations. It is confirmed that the pellets capsule produced in this study is bioequivalent with Meptin-mini tablet.


Subject(s)
Adrenergic beta-Agonists/pharmacokinetics , Procaterol/pharmacokinetics , Technology, Pharmaceutical , Administration, Oral , Adrenergic beta-Agonists/administration & dosage , Adrenergic beta-Agonists/chemistry , Adult , Capsules , Chromatography, High Pressure Liquid , Cross-Over Studies , Humans , Male , Procaterol/administration & dosage , Procaterol/chemistry , Quality Control , Solubility , Tablets , Therapeutic Equivalency
3.
Biochim Biophys Acta ; 1166(1): 39-47, 1993 Feb 10.
Article in English | MEDLINE | ID: mdl-8431491

ABSTRACT

The intrinsic surface activity of a 36 kDa rabbit lung calcium-dependent phospholipid-binding protein (PLBP), a member of the annexin family of such proteins, at the air/water interface has been determined from measurements of surface tension of aqueous solutions, and surface concentration of 14C-labeled PLBP adsorbed from aqueous solution in the absence and presence of Ca2+. It was also possible to spread insoluble monolayers of PLBP to determine surface pressure vs. surface concentration isotherms, as well as surface elasticity and surface viscosity as a function of frequency from electrocapillary wave diffraction measurements. PLBP has been shown to exhibit significant intrinsic surface activity at the air/water interface, comparable to a variety of other hydrophobic proteins known to be quite surface active. In all cases, surface properties were enhanced by the presence of Ca2+, particularly the degree of surface viscoelasticity at close-packing in the monolayer. This is believed to reflect changes in protein conformation at the surface.


Subject(s)
Annexins/isolation & purification , Calcium/chemistry , Lung/chemistry , Animals , Annexins/chemistry , Electromagnetic Phenomena , Rabbits , Surface Properties , Surface Tension , Viscosity
SELECTION OF CITATIONS
SEARCH DETAIL
...